Abstract:Background: Autophagy, a catabolic degradation process, has been shown to promote and inhibit cell growth. Results: ULK2, an upstream autophagy initiator, is silenced by methylation in glioblastoma, and its ectopic expression inhibited astrocyte transformation and glioma cell growth through autophagy. Conclusion: ULK2 down-regulation is important for the astrocyte transformation and tumor growth. Significance: Autophagy inhibition is essential for glioma development.
“…DAPK1 and ATG10, which stimulate autophagy [16,17], were activated, whereas several genes known to activate autophagy, such as DRAM1, ULK2, BCL2L1, EPG5, and NPC1, were suppressed in ELK3 KD [18][19][20][21][22][23][24][25] (Fig. 1A).…”
Section: Autophagy Is Impaired By Suppression Of Elk3 In Mda-mb-231 Cmentioning
“…DAPK1 and ATG10, which stimulate autophagy [16,17], were activated, whereas several genes known to activate autophagy, such as DRAM1, ULK2, BCL2L1, EPG5, and NPC1, were suppressed in ELK3 KD [18][19][20][21][22][23][24][25] (Fig. 1A).…”
Section: Autophagy Is Impaired By Suppression Of Elk3 In Mda-mb-231 Cmentioning
“…101 Methylation also has a role in autophagy regulation, with a genome-wide methylation analysis revealing hyper-methylation of the ULK2 gene, resulting in the inhibition of autophagy in glioblastoma cells. 102 Epigenetic agents such as HDACs 85 and demethylating agents 103 have already been shown to modulate autophagy, and these new findings could guide their development further as autophagy modulators.…”
Section: Cell Intrinsic Regulation Of Autophagy Points To New Therapementioning
Autophagy serves a dichotomous role in cancer and recent advances have helped delineate the appropriate settings where inhibiting or promoting autophagy may confer therapeutic efficacy in patients. Our evolving understanding of the molecular machinery responsible for the tightly controlled regulation of this homeostatic mechanism has begun to bear fruit in the way of autophagy-oriented clinical trials and promising lead compounds to modulate autophagy for therapeutic benefit. In this manuscript we review the recent preclinical and clinical therapeutic strategies that involve autophagy modulation in cancer.
“…Mitochondrial permeability transition, oxidative stress and ROS can also directly promote autophagy in the ischemic kidney 27,97,98 . ULK1, a kinase with an important role in autophagy initiation, is also induced by hypoxia in kidney tissue and the lack of this protein suppresses autophagy in ischemic models 99-102 . Hypoxia causes dissociation of mTOR and ULK1 leading to autophagy induction 99-101 .…”
Section: Introductionmentioning
confidence: 99%
“…Hypoxia causes dissociation of mTOR and ULK1 leading to autophagy induction 99-101 . In non-renal cell culture models, ULK1 interacts with mTORC1, AMPK, JNK and Beclin 1 to intervene at several steps in the autophagic and apoptotic pathways 48,99-102 . Yet another recently discovered mechanism, clusterin, a chaperone-like protein was shown to be required for autophagy induction 103 .…”
Summary
Many common renal insults such as ischemia and toxic injury primarily target the tubular epithelial cells especially the highly metabolically active proximal tubular segment. Tubular epithelial cells are particularly dependent on autophagy to maintain homeostasis and respond to stressors. The pattern of autophagy in the kidney has a unique spatial and chronological signature. Recent evidence shows that there is a complex crosstalk between autophagy and various cell death pathways. The purpose of this review is to specifically discuss the interplay between autophagy and cell death in the renal tubular epithelia. It is imperative to review this topic because recent discoveries have improved our mechanistic understanding of the autophagic process and have highlighted its broad clinical applications, making autophagy a major target for drug development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.